Intratumor and Intertumor Heterogeneity in Melanoma

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

Cancer statistics, 2016

Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003

Cancer Statistics, 2017.

Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471

Cancer treatment and survivorship statistics, 2016

Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944

Genomic classification of cutaneous melanoma

Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151

Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells

Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051

Tumour evolution inferred by single-cell sequencing

Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598

The causes and consequences of genetic heterogeneity in cancer evolution

Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262

Efficient tumour formation by single human melanoma cells

Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737

Tumor heterogeneity: Causes and consequences

Marusyk, A., & Polyak, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.002 · Cited by 1,602

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462

Identification of cells initiating human melanomas

Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,415

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379

A tumorigenic subpopulation with stem cell properties in melanomas

Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E., & Herlyn, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1343 · Cited by 1,280

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

Tirosh, I., Venteicher, A. S., Hebert, C., Escalante, L. E., Patel, A. P., Yizhak, K., Fisher, J. M., Rodman, C., Mount, C., Filbin, M. G., et al. (2016) · Nature · doi:10.1038/nature20123 · Cited by 1,234

The Genetic Evolution of Melanoma from Precursor Lesions

Shain, A. H., Yeh, I., Kovalyshyn, I., Sriharan, A., Talevich, E., Gagnon, A., Dummer, R., North, J., Pincus, L., Ruben, B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502583 · Cited by 1,065

Stem cell concepts renew cancer research

Dick, J. E. (2008) · Blood · doi:10.1182/blood-2008-08-077941 · Cited by 1,010

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

Zhang, J., Fujimoto, J., Zhang, J., Wedge, D. C., Song, X., Zhang, J., Seth, S., Chow, C.-W., Cao, Y., Gumbs, C., et al. (2014) · Science · doi:10.1126/science.1256930 · Cited by 965

The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma

Van Allen, E. M., Wagle, N., Sucker, A., Treacy, D. J., Johannessen, C. M., Goetz, E. M., Place, C. S., Taylor-Weiner, A., Whittaker, S., Kryukov, G. V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0617 · Cited by 912

Genetic variegation of clonal architecture and propagating cells in leukaemia

Anderson, K., Lutz, C., van Delft, F. W., Bateman, C. M., Guo, Y., Colman, S. M., Kempski, H., Moorman, A. V., Titley, I., Swansbury, J., et al. (2011) · Nature · doi:10.1038/nature09650 · Cited by 806

Pan-cancer analysis of the extent and consequences of intratumor heterogeneity

Andor, N., Graham, T. A., Jansen, M., Xia, L. C., Aktipis, C. A., Petritsch, C., Ji, H. P., & Maley, C. C. (2016) · Nature Medicine · doi:10.1038/nm.3984 · Cited by 768

In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States

Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2491 · Cited by 743

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

Boiko, A. D., Razorenova, O. V., van de Rijn, M., Swetter, S. M., Johnson, D. L., Ly, D. P., Butler, P. D., Yang, G. P., Joshua, B., Kaplan, M. J., et al. (2010) · Nature · doi:10.1038/nature09161 · Cited by 720

Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma

Snuderl, M., Fazlollahi, L., Le, L. P., Nitta, M., Zhelyazkova, B. H., Davidson, C. J., Akhavanfard, S., Cahill, D. P., Aldape, K. D., Betensky, R. A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.005 · Cited by 707

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work

Gillies, R. J., Verduzco, D., & Gatenby, R. A. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3298 · Cited by 684

Melanoma epidemiology and trends

Garbe, C., & Leiter, U. (2009) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.001 · Cited by 657

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Müller, J., Krijgsman, O., Tsoi, J., Robert, L., Hugo, W., Song, C., Kong, X., Possik, P. A., Cornelissen-Steijger, P. D. M., Foppen, M. H. G., et al. (2014) · Nature Communications · doi:10.1038/ncomms6712 · Cited by 639

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

Landsberg, J., Kohlmeyer, J., Renn, M., Bald, T., Rogava, M., Cron, M., Fatho, M., Lennerz, V., Wölfel, T., Hölzel, M., et al. (2012) · Nature · doi:10.1038/nature11538 · Cited by 632

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness

Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K. S., Testori, A., Larue, L., & Goding, C. R. (2006) · Genes & Development · doi:10.1101/gad.406406 · Cited by 608

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

Hugo, W., Shi, H., Sun, L., Piva, M., Song, C., Kong, X., Moriceau, G., Hong, A., Dahlman, K. B., Johnson, D. B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.061 · Cited by 600

Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized

Quintana, E., Shackleton, M., Foster, H. R., Fullen, D. R., Sabel, M. S., Johnson, T. M., & Morrison, S. J. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.012 · Cited by 599

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

Mahoney, K. M., Freeman, G. J., & McDermott, D. F. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.02.018 · Cited by 571

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential

Monzani, E., Facchetti, F., Galmozzi, E., Corsini, E., Benetti, A., Cavazzin, C., Gritti, A., Piccinini, A., Porro, D., Santinami, M., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.017 · Cited by 556

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

Hoek, K. S., Schlegel, N. C., Brafford, P., Sucker, A., Ugurel, S., Kumar, R., Weber, B. L., Nathanson, K. L., Phillips, D. J., Herlyn, M., et al. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00322.x · Cited by 555

Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response

Szerlip, N. J., Pedraza, A., Chakravarty, D., Azim, M., McGuire, J., Fang, Y., Ozawa, T., Holland, E. C., Huse, J. T., Jhanwar, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114033109 · Cited by 538

A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors

Konieczkowski, D. J., Johannessen, C. M., Abudayyeh, O., Kim, J. W., Cooper, Z. A., Piris, A., Frederick, D. T., Barzily-Rokni, M., Straussman, R., Haq, R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0424 · Cited by 535

Inferring tumor progression from genomic heterogeneity

Navin, N., Krasnitz, A., Rodgers, L., Cook, K., Meth, J., Kendall, J., Riggs, M., Eberling, Y., Troge, J., Grubor, V., et al. (2010) · Genome Research · doi:10.1101/gr.099622.109 · Cited by 524

Cancer stem cells versus phenotype‐switching in melanoma

Hoek, K. S., & Goding, C. R. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00757.x · Cited by 506

Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state

Verfaillie, A., Imrichova, H., Atak, Z. K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., Luciani, F., Van den Mooter, L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7683 · Cited by 489

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer

Klein, C. A., Blankenstein, T. J., Schmidt-Kittler, O., Petronio, M., Polzer, B., Stoecklein, N. H., & Riethmüller, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09838-0 · Cited by 479

BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma

Colombino, M., Capone, M., Lissia, A., Cossu, A., Rubino, C., De Giorgi, V., Massi, D., Fonsatti, E., Staibano, S., Nappi, O., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.2452 · Cited by 471

Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells

Notta, F., Mullighan, C. G., Wang, J. C. Y., Poeppl, A., Doulatov, S., Phillips, L. A., Ma, J., Minden, M. D., Downing, J. R., & Dick, J. E. (2011) · Nature · doi:10.1038/nature09733 · Cited by 463

The melanocyte differentiation program predisposes to metastasis after neoplastic transformation

Gupta, P. B., Kuperwasser, C., Brunet, J.-P., Ramaswamy, S., Kuo, W.-L., Gray, J. W., Naber, S. P., & Weinberg, R. A. (2005) · Nature Genetics · doi:10.1038/ng1634 · Cited by 439

The gene expression signatures of melanoma progression

Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433

How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine

Gerlinger, M., & Swanton, C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605912 · Cited by 421

Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis: BRAF and NRAS mutations in melanoma

Lee, J.-H., Choi, J.-W., & Kim, Y.-S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10185.x · Cited by 419

PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PD ‐ L 1 clinical trials

Madore, J., Vilain, R. E., Menzies, A. M., Kakavand, H., Wilmott, J. S., Hyman, J., Yearley, J. H., Kefford, R. F., Thompson, J. F., Long, G. V., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12340 · Cited by 398

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

Omholt, K., Platz, A., Kanter, L., Ringborg, U. K., & Hansson, J. (2003) · PubMed · Cited by 394

Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

Li, S., Garrett-Bakelman, F. E., Chung, S. S., Sanders, M. A., Hricik, T., Rapaport, F., Patel, J., Dillon, R., Vijay, P., Brown, A. L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4125 · Cited by 387

Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing

Campbell, P. J., Pleasance, E. D., Stephens, P. J., Dicks, E., Rance, R., Goodhead, I., Follows, G. A., Green, A. R., Futreal, P. A., & Stratton, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801523105 · Cited by 365

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

Gray, E. S., Rizos, H., Reid, A. L., Boyd, S. C., Pereira, M. R., Lo, J., Tembe, V., Freeman, J., Lee, J. H. J., Scolyer, R. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5788 · Cited by 336

Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth

Civenni, G., Walter, A., Kobert, N., Mihic-Probst, D., Zipser, M., Belloni, B., Seifert, B., Moch, H., Dummer, R., van den Broek, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3997 · Cited by 326

Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype

Park, S. Y., Gönen, M., Kim, H. J., Michor, F., & Polyak, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40724 · Cited by 324

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing

Edlundh-Rose, E., Egyha??zi, S., Omholt, K., Mansson-Brahme, E., Platz, A., Hansson, J., & Lundeberg, J. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000232300.22032.86 · Cited by 318

The evolution of tumour phylogenetics: principles and practice

Schwartz, R., & Schäffer, A. A. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.170 · Cited by 318

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

Dong, J., Phelps, R. G., Qiao, R., Yao, S., Benard, O., Ronai, Z. A., & Aaronson, S. A. (2003) · PubMed · Cited by 310

Intratumor Heterogeneity in Hepatocellular Carcinoma

Friemel, J., Rechsteiner, M., Frick, L., Böhm, F., Struckmann, K., Egger, M., Moch, H., Heikenwalder, M., & Weber, A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0122 · Cited by 296

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis.

Houben, R., Becker, J. C., Kappel, A., Terheyden, P. A. M., Bröcker, E., Goetz, R., & Rapp, U. R. (2004) · Journal of Carcinogenesis · doi:10.1186/1477-3163-3-6 · Cited by 294

Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma

Yancovitz, M., Litterman, A., Yoon, J., Ng, E., Shapiro, R. L., Berman, R. S., Pavlick, A. C., Darvishian, F., Christos, P., Mazumdar, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029336 · Cited by 283

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma

Falletta, P., Sanchez-del-Campo, L., Chauhan, J., Effern, M., Kenyon, A., Kershaw, C. J., Siddaway, R., Lisle, R., Freter, R., Daniels, M. J., et al. (2017) · Genes & Development · doi:10.1101/gad.290940.116 · Cited by 239

Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state

Fallahi‐Sichani, M., Becker, V., Izar, B., Baker, G. J., Lin, J., Boswell, S. A., Shah, P., Rotem, A., Garraway, L. A., & Sorger, P. K. (2017) · Molecular Systems Biology · doi:10.15252/msb.20166796 · Cited by 235

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

Geyer, F. C., Weigelt, B., Natrajan, R., Lambros, M. B., de Biase, D., Vatcheva, R., Savage, K., Mackay, A., Ashworth, A., & Reis‐Filho, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2675 · Cited by 233

MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment

Riesenberg, S., Groetchen, A., Siddaway, R., Bald, T., Reinhardt, J., Smorra, D., Kohlmeyer, J., Renn, M., Phung, B., Aymans, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9755 · Cited by 227

Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine

Sigalotti, L., Fratta, E., Coral, S., Tanzarella, S., Danielli, R., Colizzi, F., Fonsatti, E., Traversari, C., Altomonte, M., & Maio, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1442 · Cited by 217

The NF1 gene in tumor syndromes and melanoma

Kiuru, M., & Busam, K. J. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2016.142 · Cited by 217

Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy

Kemper, K., de Goeje, P. L., Peeper, D. S., & van Amerongen, R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1174 · Cited by 216

Incidence of BRAF Oncogene Mutation and Clinical Relevance for Primary Cutaneous Melanomas

Shinozaki, M., Fujimoto, A., Morton, D. L., & Hoon, D. S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1169-3 · Cited by 212

Cancer stem cells and human malignant melanoma

Schatton, T., & Frank, M. H. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00427.x · Cited by 210

Direct Genetic Analysis of Single Disseminated Cancer Cells for Prediction of Outcome and Therapy Selection in Esophageal Cancer

Stoecklein, N. H., Hosch, S. B., Bezler, M., Stern, F., Hartmann, C. H., Vay, C., Siegmund, A., Scheunemann, P., Schurr, P., Knoefel, W. T., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.005 · Cited by 209

Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion

Chapman, A., Fernandez del Ama, L., Ferguson, J., Kamarashev, J., Wellbrock, C., & Hurlstone, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.045 · Cited by 203

Metapopulation dynamics and spatial heterogeneity in cancer

González-García, I., Solé, R. V., & Costa, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202139299 · Cited by 201

Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination

Sanborn, J. Z., Chung, J., Purdom, E., Wang, N. J., Kakavand, H., Wilmott, J. S., Butler, T., Thompson, J. F., Mann, G. J., Haydu, L. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508074112 · Cited by 192

Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma

Sensi, M., Nicolini, G., Petti, C., Bersani, I., Lozupone, F., Molla, A., Vegetti, C., Nonaka, D., Mortarini, R., Parmiani, G., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209379 · Cited by 183

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

Reuben, A., Spencer, C. N., Prieto, P. A., Gopalakrishnan, V., Reddy, S. M., Miller, J. P., Mao, X., De Macedo, M. P., Chen, J., Song, X., et al. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0013-8 · Cited by 166 · cited 4×

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls

Horak, P., Fröhling, S., & Glimm, H. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000094 · Cited by 165

Phenotype Switching in Melanoma: Implications for Progression and Therapy

Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G., & Ferrao, P. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00031 · Cited by 163

Genetic divergence in the clonal evolution of breast cancer.

Fujii, H., Marsh, C., Cairns, P., Sidransky, D., & Gabrielson, E. (1996) · PubMed · Cited by 163

Whole genome sequencing of matched primary and metastatic acral melanomas

Turajlic, S., Furney, S. J., Lambros, M. B., Mitsopoulos, C., Kozarewa, I., Geyer, F. C., MacKay, A., Hakas, J., Zvelebil, M., Lord, C. J., et al. (2012) · Genome Research · doi:10.1101/gr.125591.111 · Cited by 163

Precise microdissection of human prostate cancers reveals genotypic heterogeneity.

Macintosh, C. A., Stower, M. J., Reid, N., et al. (1998) · PubMed · Cited by 162

Detection of BRAF p.V600E Mutations in Melanomas

Colomba, E., Hélias-Rodzewicz, Z., Von Deimling, A., Marin, C., Terrones, N., Pechaud, D., Surel, S., Côté, J.-F., Peschaud, F., Capper, D., et al. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.09.001 · Cited by 160

PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison

Sunshine, J. C., Nguyen, P. L., Kaunitz, G. J., Cottrell, T. R., Berry, S., Esandrio, J., Xu, H., Ogurtsova, A., Bleich, K. B., Cornish, T. C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1821 · Cited by 158

Complex patterns of ETS gene alteration arise during cancer development in the human prostate

Clark, J., Attard, G., Jhavar, S. G., Flohr, P., Reid, A. H. M., Bono, J. S. D., Eeles, R. A., Scardino, P. T., Cuzick, J. M., Fisher, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210843 · Cited by 156

A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma

Merlo, L. M. F., Shah, N. A., Li, X., Blount, P. L., Vaughan, T. L., Reid, B. J., & Maley, C. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0108 · Cited by 155

Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.

Fujii, H., Yoshida, M., Gong, Z. X., Matsumoto, T., Hamano, Y., Fukunaga, M., Hruban, R. H., Gabrielson, E., & Shirai, T. (2000) · PubMed · Cited by 153

Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching

Widmer, D. S., Hoek, K. S., Cheng, P. F., Eichhoff, O. M., Biedermann, T., Raaijmakers, M. I. G., Hemmi, S., Dummer, R., & Levesque, M. P. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.115 · Cited by 148

Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic Melanoma

Halait, H., DeMartin, K., Shah, S., Soviero, S., Langland, R., Cheng, S., Hillman, G. R., Wu, L., & Lawrence, H. J. (2012) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e31823b216f · Cited by 145

Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts

Kemper, K., Krijgsman, O., Cornelissen‐Steijger, P., Shahrabi, A., Weeber, F., Song, J., Kuilman, T., Vis, D. J., Wessels, L. F. A., Voest, E. E., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404914 · Cited by 141

Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma

Anderson, S., Bloom, K. J., Vallera, D. U., Rueschoff, J., Meldrum, C. J., Schilling, R., Kovach, B., Lee, J. R.-J., Ochoa, P., Langland, R., et al. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0505-oa · Cited by 139

Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling

Govindarajan, B., Bai, X., Cohen, C., Zhong, H., Kilroy, S. M., Louis, G. W., Moses, M. A., & Arbiser, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212929200 · Cited by 130

Advances in Immunotherapy for Melanoma: A Comprehensive Review

Rodríguez‐Cerdeira, C., Carnero-Gregorio, M., López-Bárcenas, A., Sánchez-Blanco, E., Sánchez-Blanco, B., Fabbrocini, G., Bardhi, B., Sinani, A., & Arenas, R. (2017) · Mediators of Inflammation · doi:10.1155/2017/3264217 · Cited by 130

Eradication of melanomas by targeted elimination of a minor subset of tumor cells

Schmidt, P., Kopecky, C., Hombach, A. A., Zigrino, P., Mauch, C., & Abken, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009069108 · Cited by 129

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression

Lin, J., Goto, Y., Murata, H., Sakaizawa, K., Uchiyama, A., Saida, T., & Takata, M. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606072 · Cited by 122

Intratumoral Heterogeneity in Breast Carcinoma Revealed by Laser-Microdissection and Comparative Genomic Hybridization

Aubele, M. M., Mattis, A. E., Zitzelsberger, H. F., Walch, A. K., Kremer, M., Hutzler, P., Höfler, H., & Werner, M. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00205-2 · Cited by 122

Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.

Okada, Y., Hurwitz, E. E., Esposito, J. M., et al. (2003) · PubMed · Cited by 118

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma

Harbst, K., Lauss, M., Cirenajwis, H., Isaksson, K., Rosengren, F., Törngren, T., Kvist, A., Johansson, M. C., Vallon‐Christersson, J., Baldetorp, B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3476 · Cited by 110

Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell

Held, M. A., Curley, D. P., Dankort, D. L., McMahon, M., Muthusamy, V., & Bosenberg, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2153 · Cited by 109

Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing

Boursault, L., Haddad, V., Vergier, B., Cappellen, D., Verdon, S., Bellocq, J., Jouary, T., & Merlio, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070826 · Cited by 108

CD133+ Melanoma Subpopulations Contribute to Perivascular Niche Morphogenesis and Tumorigenicity through Vasculogenic Mimicry

Lai, C.-Y., Schwartz, B. E., & Hsu, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0624 · Cited by 107

Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

Konishi, N., Hiasa, Y., Matsuda, H., Tao, M., Tsuzuki, T., Hayashi, I., Kitahori, Y., Shiraishi, T., Yatani, R., & Shimazaki, J. (1995) · Europe PMC (PubMed Central) · Cited by 105

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

Botti, G., Fratangelo, F., Cerrone, M., Liguori, G., Cantile, M., Anniciello, A. M., Scala, S., D’Alterio, C., Trimarco, C., Ianaro, A., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1150-7 · Cited by 104

Immunohistochemical Analysis of BRAFV600E Expression of Primary and Metastatic Melanoma and Comparison With Mutation Status and Melanocyte Differentiation Antigens of Metastatic Lesions

BUSAM, K. J., Hedvat, C. V., Pulitzer, M. P., von Deimling, A., & Jungbluth, A. A. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318271249e · Cited by 104

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level

Sakaizawa, K., Goto, Y., Kiniwa, Y., Uchiyama, A., Harada, K., Shimada, S., Saida, T., Ferrone, S., Takata, M., Uhara, H., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.12 · Cited by 103

Intratumoral Heterogeneity of Immunohistochemical Marker Expression in Breast Carcinoma

Nassar, A., Radhakrishnan, A., Cabrero, I. A., Cotsonis, G., & Cohen, C. (2010) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3181dddb20 · Cited by 100

Single-cell gene expression signatures reveal melanoma cell heterogeneity

Ennen, M., Keime, C., Kobi, D., Mengus, G., Lipsker, D. M., Thibault-Carpentier, C., & Davidson, I. (2014) · Oncogene · doi:10.1038/onc.2014.262 · Cited by 97

Intra‐tumour heterogeneity – going beyond genetics

Caiado, F., Silva‐Santos, B., & Norell, H. (2016) · FEBS Journal · doi:10.1111/febs.13705 · Cited by 96

Tumor Evolution and Intratumor Heterogeneity of an Oropharyngeal Squamous Cell Carcinoma Revealed by Whole-Genome Sequencing

Zhang, X. C., Xu, C., Mitchell, R. M., Zhang, B., Zhao, D., Li, Y., Huang, X. H., Fan, W., Wang, H., Lerma, L. A., et al. (2013) · Neoplasia · doi:10.1593/neo.131400 · Cited by 92

Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance

Luo, Y., Ellis, L. Z., Dallaglio, K., Takeda, M. R., Robinson, W. A., Robinson, S. E., Liu, W., Lewis, K. D., McCarter, M. D., Gonzalez, R. C., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.161 · Cited by 88

Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment

Gray, E. S., Reid, A. L., Bowyer, S. E., Calapre, L., Siew, K. S. W., Pearce, R. L., Cowell, L., Frank, M. H., Millward, M., & Ziman, M. R. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.127 · Cited by 86

Clonal Architectures and Driver Mutations in Metastatic Melanomas

Ding, L., Kim, M., Kanchi, K., Dees, N. D., Lu, C., Griffith, M., Fenstermacher, D., Sung, H., Miller, C. A., Goetz, B. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111153 · Cited by 85

The Wnts of change: How Wnts regulate phenotype switching in melanoma

Webster, M. R., Kugel, C. H., & Weeraratna, A. T. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.002 · Cited by 83

Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer

Cottu, P. H., Asselah, J., Lae, M. E., Pierga, J., Dieras, V. C., Mignot, L., Sigal‐Zafrani, B., & Vincent‐Salomon, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn021 · Cited by 82

Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma

Kumar, D., Gorain, M., Kundu, G., & Kundu, G. C. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0578-3 · Cited by 80

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel

Bustos, B. D. U., Estal, R. M., Pérez-Simó, G., Jiménez, I. D. J., Muñoz, B. E., Serna, M. R., de Miquel, V. A., Ros, M. L., Sánchez, R. B., Nagore, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00606-w · Cited by 78

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines

Kim, J. E., Leung, E. Y., Baguley, B. C., & Finlay, G. J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00097 · Cited by 76

Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine

Wilmott, J. S., Tembe, V., Howle, J. R., Sharma, R. N., Thompson, J. F., Rizos, H., Lo, R. S., Kefford, R. F., Scolyer, R. A., & Long, G. V. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0530 · Cited by 76

Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq

Gerber, T., Willscher, E., Loeffler‐Wirth, H., Hopp, L., Schadendorf, D., Schartl, M., Anderegg, U., Camp, J. G., Treutlein, B., Binder, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13666 · Cited by 76

Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors

Goswami, R. S., Patel, K. P., Singh, R. R., Meric‐Bernstam, F., Kopetz, S., Subbiah, V., Álvarez, R. H., Davies, M. A., Jabbar, K. J., Roy‐Chowdhuri, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2391 · Cited by 75

Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis

Chatterjee, A., Stockwell, P. A., Ahn, A., Rodger, E. J., Leichter, A. L., & Eccles, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.14042 · Cited by 73

Molecular and genetic diversity in the metastatic process of melanoma

Harbst, K., Lauss, M., Cirenajwis, H., Winter, C., Howlin, J., Törngren, T., Kvist, A., Nodin, B., Olsson, E., Häkkinen, J., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4318 · Cited by 72

Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing

Varley, K. E., Mutch, D. G., Edmonston, T. B., Goodfellow, P. J., & Mitra, R. D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp457 · Cited by 72

Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy.

Giaretti, W., Monaco, R., Pujič, N., Rapallo, A., Nigro, S., & Geido, E. (1996) · PubMed · Cited by 71

Investigating the utility of human melanoma cell lines as tumour models

Vincent, K. M., & Postovit, L.-M. M. (2017) · Oncotarget · doi:10.18632/oncotarget.14443 · Cited by 70

Intravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cells

Manning, C. S., Hooper, S., & Sahai, E. A. (2014) · Oncogene · doi:10.1038/onc.2014.362 · Cited by 69

Genetically Heterogeneous and Clonally Unrelated Metastases May Arise in Patients With Cutaneous Melanoma

Katona, T. M., Jones, T. D., Wang, M., Eble, J. N., Billings, S. D., & Cheng, L. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31802b3488 · Cited by 67

Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA

Gremel, G., Lee, R. J., Girotti, M. R., Mandal, A. K., Valpione, S., Garner, G., Ayub, M., Wood, S. L., Rothwell, D. G., Fusi, A., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw278 · Cited by 59

Testing the cancer stem cell hypothesis in melanoma: The clinics will tell

Shakhova, O., & Sommer, L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.009 · Cited by 57

Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.

Rastetter, M., Schagdarsurengin, U., Lahtz, C., Fiedler, E., Marsch, W. C., Dammann, R., & Helmbold, P. (2007) · PubMed · doi:10.14670/hh-22.1005 · Cited by 55

Somatic Mosaicism and Cancer: A Micro-Genetic Examination into the Role of the Androgen Receptor Gene in Prostate Cancer

Alvarado, C., Beitel, L. K., Sircar, K., Aprikian, A. G., Trifiro, M. A., & Gottlieb, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0399 · Cited by 55

Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature

Anwar, M. A. F., Murad, F. G., Dawson, E., Elmageed, Z. Y. A., Tsumagari, K., & Kandil, E. H. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.04.029 · Cited by 54

BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma

Chiappetta, C., Proietti, I., Soccodato, V., Puggioni, C., Zaralli, R., Pacini, L., Porta, N., Skroza, N., Petrozza, V., Potenza, C., et al. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000071 · Cited by 53

The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis

Wouters, J., Stas, M., Gremeaux, L., Govaere, O., den broeck, A. V., Maes, H., Agostinis, P., Roskams, T., van den Oord, J. J., & Vankelecom, H. E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076550 · Cited by 52

Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma

Cao, W., Wu, W., Yan, M., Tian, F., Ma, C., Zhang, Q., Li, X., Han, P., Liu, Z., Gu, J., et al. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.34 · Cited by 52

Variations of BRAF mutant allele percentage in melanomas

Hélias‐Rodzewicz, Z., Funck‐Brentano, E., Baudoux, L., Jung, C. K., Zimmermann, U. S., Marin, C., Clérici, T., Gall, C. L., Peschaud, F., Taly, V., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1515-3 · Cited by 51

Discrepancy in BRAF status among patients with metastatic malignant melanoma: A meta-analysis

Valachis, A., & Ullenhag, G. J. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.015 · Cited by 51

Intra- and Inter-Tumoral Homogeneity of BRAFV600E Mutations in Melanoma Tumors

Riveiro‐Falkenbach, E., Villanueva, C. A., Garrido, M. C., Ruano, Y., García-Martín, R., Godoy, E., Ortiz-Romero, P. L., Ríos-Martín, J. J., Santos-Briz, A. J., & Rodríguez‐­Peralto, J. L. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.229 · Cited by 47

Circulating tumor cells: Exploring intratumor heterogeneity of colorectal cancer

Raimondi, C., Nicolazzo, C., Gradilone, A., Giannini, G., FALCO, E. D., Chimenti, I., Varriale, E., Hauch, S., Plappert, L., Cortesi, E., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28020 · Cited by 47

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry

Bruno, W., (IMI), O. B. O. T. I. M. I., Martinuzzi, C., Andreotti, V., Pastorino, L., Spagnolo, F., Dalmasso, B., Cabiddu, F., Gualco, M., Ballestrero, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14094 · Cited by 46

Melanoma Tumor Cell Heterogeneity: A Molecular Approach to Study Subpopulations Expressing the Embryonic Morphogen Nodal

Seftor, E. A., Seftor, R. E. B., Weldon, D. S., Kirsammer, G. T., Margaryan, N. V., Gilgur, A., & Hendrix, M. J. C. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.001 · Cited by 42

Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy

Bradish, J. R., Richey, J. D., Post, K. M., Meehan, K. L., Sen, J. D., Malek, A. J., Katona, T. M., Warren, S. J. P., Logan, T. F., Fecher, L. A., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.136 · Cited by 42

Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive Melanoma

Demou, Z. N., & Hendrix, M. J. C. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21855 · Cited by 40

Therapeutic implications of melanoma heterogeneity

Hachey, S. J., & Boiko, A. D. (2016) · Experimental Dermatology · doi:10.1111/exd.13002 · Cited by 40

NGFR-Positive Desmoplastic Melanomas with Focal or Absent S-100 Staining

Radfar, A., Stefanato, C. M., Ghosn, S. H., & Bhawan, J. (2006) · American Journal of Dermatopathology · doi:10.1097/01.dad.0000183696.46573.ee · Cited by 39

Genetic heterogeneity and clonal evolution in neuroblastoma

Mora, J., Cheung, N.-K. V., & Gerald, W. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1849 · Cited by 38

Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis

Takata, M., Morita, R., & Takehara, K. (2000) · International Journal of Cancer · Cited by 38

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies

Lamy, P., Castan, F., Lozano, N., Montélion, C., Audran, P., Bibeau, F., Roques, S., Montels, F., & Laberenne, A.-C. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.02.004 · Cited by 37

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma

Marino, F. Z., Liguori, G., Aquino, G., Mantia, E. L., Bòsari, S., Ferrero, S., Rosso, L., Gaudioso, G., Rosa, N. D., Scrima, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139264 · Cited by 37

Highly Concordant Results Between Immunohistochemistry and Molecular Testing of Mutated V600E BRAF in Primary and Metastatic Melanoma

Manfredi, L., Meyer, N., Tournier, É., Grand, D., Uro‐Coste, E., Rochaix, P., Brousset, P., & Lamant, L. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2326 · Cited by 36

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

Anaka, M., Hudson, C., Lo, P., Do, H., Caballero, O. L., Davis, I. D., Dobrovic, A., Cebon, J. S., & Behren, A. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-40 · Cited by 35

Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases

Pennec, S. L., Konopka, T., Gacquer, D., Fimereli, D., Tarabichi, M., Tomás, G., Savagner, F., Decaussin‐Petrucci, M., Trésallet, C., Andry, G., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0351 · Cited by 35

BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma

Yaman, B., Kandiloğlu, G., & Akalın, T. (2015) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000000404 · Cited by 34

Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity.

Benetkiewicz, M., Piotrowski, A., de Ståhl, T. D., Jankowski, M., Bała, D., Hoffman, J., Śrutek, E., Laskowski, R., Zegarski, W., & Dumanski, J. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.4.935 · Cited by 33

Phenotypic diversity of patient-derived melanoma populations in stem cell medium

Sztiller-Sikorska, M., Hartman, M. L., Talar, B., Jakubowska, J., Zaleśna, I., & Czyż, M. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.48 · Cited by 33

BRAFV600EProtein Expression in Primary Cutaneous Malignant Melanomas and Paired Metastases

Eriksson, H., Zebary, A., Vassilaki, I., Omholt, K., Ghaderi, M., & Hansson, J. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.3689 · Cited by 32

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

Schirosi, L., Strippoli, S., Gaudio, F. D., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2951-4 · Cited by 32

Future of circulating tumor cells in the melanoma clinical and research laboratory settings

Souza, L. M. D., Robertson, B. M., & Robertson, G. P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.023 · Cited by 32

Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?

Brinckerhoff, C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25796 · Cited by 31

Analysis of intratumor heterogeneity unravels lung cancer evolution

de Bruin, E. C., McGranahan, N., & Swanton, C. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.985549 · Cited by 29

Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas

Richmond‐Sinclair, N. M., Lee, E., Cummings, M. C., Williamson, R., Müller, K., Green, A. C., Hayward, N. K., & Whiteman, D. C. (2008) · Melanoma Research · doi:10.1097/cmr.0b013e32830d8329 · Cited by 27

Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: A clue for intra- and inter-tumor heterogeneity

Kaji, T., Yamasaki, O., Takata, M., Otsuka, M., Hamada, T., Morizane, S., Asagoe, K., Yanai, H., Hirai, Y., Umemura, H., et al. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.10.006 · Cited by 27

Update on the clinical use of kinase inhibitors in melanoma

Cosgarea, I., Ritter, C., Becker, J. C., Schadendorf, D., & Ugurel, S. (2017) · Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · doi:10.1111/ddg.13321 · Cited by 27

Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: Implications on optimized targeted therapy

Saroufim, M., Habib, R., Gerges, R., Saab, J., Loya, A., Amr, S. S., Sheikh, S. S., Satti, M., Oberkanins, C., & Khalifeh, I. M. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.09.008 · Cited by 26

Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma

Sharma, B. K., Manglik, V., O’Connell, M. P., Weeraratna, A. T., McCarron, E. C., Broussard, J., DiVito, K. A., Simbulan-Rosenthal, C. M., Rosenthal, D. S., & Zapas, J. L. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1590 · Cited by 25

Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance.

Martínez‐Cardús, A., Vizoso, M., Morán, S., & Manzano, J. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.06.20 · Cited by 24

Update on melanoma epigenetics

de Unamuno, B., Palanca, S., & Botella, R. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000217 · Cited by 22

Varying Mutational Alterations in Multiple Primary Melanomas

Egberts, F., Bohne, A., Krüger, S., Hedderich, J., Rompel, R., Haag, J., Röcken, C., & Hauschild, A. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.07.010 · Cited by 21

Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis

Kaisaki, P. J., Cutts, A., Popitsch, N. P., Camps, C., Pentony, M. M., Wilson, G. A., Page, S., Kaur, K., Vavoulis, D. V., Henderson, S. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162809 · Cited by 21

Liquid Biopsies for Assessing Metastatic Melanoma Progression

Huynh, K. T., & Hoon, D. S. �. (2016) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2016016075 · Cited by 19

Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma

Ardakani, N. M., Leslie, C., Grieu‐Iacopetta, F., et al. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12569 · Cited by 19

Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R

Mirkina, I. I., Hadzijusufovic, E., Krepler, C., Mikula, M., Mechtcheriakova, D., Strommer, S., Stella, A., Jensen‐Jarolim, E., Höeller, C., Wacheck, V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084417 · Cited by 18

An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 Negative

Lenggenhager, D. M., Fontecedro, A. C., Storz, M., Shakhova, O., Sommer, L., Widmer, D. S., Seifert, B., Moch, H., Dummer, R., & Mihic‐Probst, D. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.02.018 · Cited by 16

Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma.

Chang, M. Y., Rao, N. P., Burgess, B. L., Johnson, L., & McCannel, T. A. (2013) · Europe PMC (PubMed Central) · Cited by 15

BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells: A STROBE-Compliant article

Verlinden, I. V., van den Hurk, K., Clarijs, R., Willig, A. P., Stallinga, C. M., Roemen, G. M. J. M., van den Oord, J. J., Hausen, A. Z., Speel, E. M., & Winnepenninckx, V. J. L. (2014) · Medicine · doi:10.1097/md.0000000000000285 · Cited by 15

Melanoma stem cells

Roesch, A. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12584 · Cited by 14

The extent of whole‐genome copy number alterations predicts aggressive features in primary melanomas

Gandolfi, G., Longo, C., Moscarella, E., Zalaudek, I., Sancisi, V., Raucci, M., Manzotti, G., Gugnoni, M., Piana, S., Argenziano, G., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12436 · Cited by 14

Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma

Casula, M., Colombino, M., Manca, A., Caracò, C., Botti, G., Ascierto, P. A., Lissia, A., Cossu, A., Palmieri, G., Mozzillo, N., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.103 · Cited by 14

Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution

Erramuzpe, A., Cortés, J. M., & Lopez, J. I. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2223-y · Cited by 11

Intratumoral DNA stem-line heterogeneity in superficial spreading melanoma

Helmbold, P., Altrichter, D., Klapperstück, T., & Marsch, W. C. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.12.049 · Cited by 9

Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation

Pongor, L. S., Papp, H., Méhes, E., Czirók, A., & Győrffy, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-07487-z · Cited by 9

Identification of genetic disparity between primary and metastatic melanoma in human patients

Swoboda, A., Rasin‐Streden, D., Schanab, O., Okamoto, I., Pehamberger, H., Petzelbauer, P., & Mikula, M. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20890 · Cited by 7

Targeting Tumor Microenvironment for Cancer Therapy

Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187

Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma

Wouters, J., Kalender-Atak, Z., Minnoye, L., Spanier, K. I., De Waegeneer, M., Bravo González-Blas, C., Mauduit, D., Davie, K., Hulselmans, G., Najem, A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0547-3 · Cited by 258

Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment

de Maar, J. S., Sofias, A. M., Porta Siegel, T., Vreeken, R. J., Moonen, C., Bos, C., & Deckers, R. (2020) · Theranostics · doi:10.7150/thno.38625 · Cited by 71

Unraveling resistance to immunotherapy in MSI-high colorectal cancer

Heregger, R., Huemer, F., Steiner, M., Gonzalez-Martinez, A., Greil, R., & Weiss, L. (2023) · Cancers · doi:10.3390/cancers15205090 · Cited by 52

Identification of Cancer Stem Cell Subpopulations in Head and Neck Metastatic Malignant Melanoma

Yoganandarajah, V., Patel, J., van Schaijik, B., Bockett, N., Brasch, H. D., Paterson, E., Sim, D., Davis, P. F., Roth, I. M., Itinteang, T., et al. (2020) · Cells · doi:10.3390/cells9020324 · Cited by 26